Celularity Inc. Income Taxes Paid
Celularity Inc. (CELU) reported Income Taxes Paid of $218.65 thousand for the 12-month period ending 2020-12-31, per its 10-K/A filed 2021-05-24.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:IncomeTaxesPaid · last filed 2021-08-19
- Celularity Inc. income taxes paid for the quarter ending 2020-12-31 was $62.50K, a 46.12% decline year-over-year.
- Celularity Inc. income taxes paid for the quarter ending 2020-09-30 was $0.00.
- Celularity Inc. income taxes paid for the quarter ending 2020-06-30 was $18.65K.
- Celularity Inc. income taxes paid for the quarter ending 2020-03-31 was $137.50K.
- Celularity Inc. income taxes paid for fiscal 2020 was $218.65K, a 66.41% decline from fiscal 2019.
- Celularity Inc. income taxes paid for fiscal 2019 was $651.00K.
| Period end | Income Taxes Paid 3 month | Income Taxes Paid 6 month | Income Taxes Paid 9 month | Income Taxes Paid 12 month |
|---|---|---|---|---|
| 2020-12-31 | $62.50K derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-05-24 | $62.50K derived: sum of 2 quarters · filed 2021-05-24 | $81.15K derived: sum of 3 quarters · filed 2021-08-19 | $218.65K 10-K/A · filed 2021-05-24 |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $18.65K derived: sum of 2 quarters · filed 2021-08-19 | $156.15K 10-Q · filed 2020-11-16 | $272.15K derived: sum of 4 quarters · filed 2021-08-19 |
| 2020-06-30 | $18.65K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-19 | $156.15K 10-Q · filed 2021-08-19 | $272.15K derived: sum of 3 quarters · filed 2021-08-19 | |
| 2020-03-31 | $137.50K 10-Q · filed 2021-05-24 | $253.50K derived: sum of 2 quarters · filed 2021-05-24 | ||
| 2019-12-31 | $116.00K derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-05-24 | $651.00K 10-K/A · filed 2021-05-24 | ||
| 2019-09-30 | $535.00K 10-Q · filed 2020-11-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |